Douglas R Smith

Oscient Pharmaceuticals Corporation

$27,922,357

Attributed

$27,922,357

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding mix

By agency

NIH$27,922,357 · 5

By mechanism

U54$25,832,724 · 2

R24$1,074,167 · 1

R44$897,527 · 1

R43$117,939 · 1

Top collaborators

No co-investigators on record.

Most similar at Oscient Pharmaceuticals Corporation

Same institution · by research overlap

James A Benn$1,444,315
Donald T Moir$17,688,060

Others in their field

Top investigators on “Nucleic Acid Sequence”

Eric S Lander · Whitehead Institute For Biomedical Res$342,610,312
Richard A Gibbs · Baylor College Of Medicine$207,797,415
Robert H Waterston · Washington University$157,055,244
Richard K. Wilson · Washington University$108,755,150
Michael P Snyder · Yale University$67,235,230
Kristin Ardlie · Genomics Collaborative, Inc.$59,282,753

Research focus

Nucleic Acid SequenceGenomeMolecular Biology Information SystemLaboratory MouseAnimal Genetic Material TagPolymerase Chain ReactionCapillary ElectrophoresisBiomedical AutomationHuman Genetic Material TagArtificial ChromosomesInformation DisseminationRestriction Fragment Length PolymorphismGenetic LibraryComputer Assisted Sequence AnalysisGenetic MappingCooperative StudyHigh Throughput TechnologyTechnology /Technique DevelopmentUltrafiltrationNeoplastic ProcessNucleic Acid PurificationBiotechnologyPharmacogeneticsBiomedical Equipment Development